Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Marshall
Fray F
FF
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D015820:Cadherins / Q000032:analysis / Q000235:genetics; D004249:DNA Damage / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis* / Q000235:genetics; D016147:Genes, Tumor Suppressor; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000235:genetics; D008745:Methylation; D025202:Molecular Diagnostic Techniques; D011237:Predictive Value of Tests; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis* / Q000235:genetics; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000032:analysis / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000032:analysis / Q000235:genetics; D014516:Ureteral Neoplasms / Q000175:diagnosis* / Q000235:genetics
D014408:Biomarkers, Tumor; D015820:Cadherins; D004273:DNA, Neoplasm; C411762:RASSF1 protein, human; D019717:Tissue Inhibitor of Metalloproteinase-3; D025521:Tumor Suppressor Proteins